Back to Journals » Infection and Drug Resistance » Volume 9 » default
Infection and Drug Resistance
ISSN: 1178-6973
- View all (3734)
- Volume 17, 2024 (340)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Archive: Volume 9, 2016
A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
Sallam MM, Abou-Aisha K, El-Azizi M
Infection and Drug Resistance 2016, 9:301-311
Published Date: 8 December 2016
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
Natesan SK, Chandrasekar PH
Infection and Drug Resistance 2016, 9:291-300
Published Date: 7 December 2016
Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis
Lau CSM, Ward A, Chamberlain RS
Infection and Drug Resistance 2016, 9:275-289
Published Date: 7 December 2016
Availability, perceptions, and characteristics of antibiograms among Illinois pediatricians
Spiekerman KM, Patel SJ, Patel R, Kociolek LK
Infection and Drug Resistance 2016, 9:269-274
Published Date: 5 December 2016
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
Vreden SGS, Bansie RD, Jitan JK, Adhin MR
Infection and Drug Resistance 2016, 9:261-267
Published Date: 24 November 2016
The pharmacokinetics of vancomycin during the initial loading dose in patients with septic shock
Katip W, Jaruratanasirikul S, Pattharachayakul S, Wongpoowarak W, Jitsurong A, Lucksiri A
Infection and Drug Resistance 2016, 9:253-260
Published Date: 22 November 2016
Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience
Hirano R, Sakamoto Y, Kitazawa J, Yamamoto S, Tachibana N
Infection and Drug Resistance 2016, 9:243-252
Published Date: 14 October 2016
Evaluating vancomycin susceptibility in Staphylococcus aureus
Mimica MJ, Navarini A
Infection and Drug Resistance 2016, 9:239-241
Published Date: 26 September 2016
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
Burgel PR, Paugam A, Hubert D, Martin C
Infection and Drug Resistance 2016, 9:229-238
Published Date: 20 September 2016
Lemierre’s syndrome: current perspectives on diagnosis and management
Johannesen KM, Bodtger U
Infection and Drug Resistance 2016, 9:221-227
Published Date: 14 September 2016
Lyme disease: the promise of Big Data, companion diagnostics and precision medicine
Stricker RB, Johnson L
Infection and Drug Resistance 2016, 9:215-219
Published Date: 13 September 2016
Peramivir injection in the treatment of acute influenza: a review of the literature
Wester A, Shetty AK
Infection and Drug Resistance 2016, 9:201-214
Published Date: 22 August 2016
Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]
Lu DD, Raman JD
Infection and Drug Resistance 2016, 9:199-200
Published Date: 23 August 2016
Pelvic inflammatory disease: improving awareness, prevention, and treatment
Das BB, Ronda J, Trent M
Infection and Drug Resistance 2016, 9:191-197
Published Date: 19 August 2016
Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro
El-Azizi M, Khardori N
Infection and Drug Resistance 2016, 9:181-189
Published Date: 19 August 2016
Early detection of neonatal group B streptococcus sepsis and the possible diagnostic utility of IL-6, IL-8, and CD11b in a human umbilical cord blood in vitro model
Nakstad B, Sonerud T, Solevåg AL
Infection and Drug Resistance 2016, 9:171-179
Published Date: 8 July 2016
Strategies for prevention of ultrasound-guided prostate biopsy infections
Lu DD, Raman JD
Infection and Drug Resistance 2016, 9:161-169
Published Date: 8 July 2016
Emerging resistant serotypes of invasive Streptococcus pneumoniae
Elshafie S, Taj-Aldeen SJ
Infection and Drug Resistance 2016, 9:153-160
Published Date: 29 June 2016
Concern over Zika virus outbreak: another alarming global threat
Hafiz MY, Mahmood SU, Shoaib M, Yusuf FH
Infection and Drug Resistance 2016, 9:149-151
Published Date: 28 June 2016
An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes
Thabit AK, Nicolau DP
Infection and Drug Resistance 2016, 9:143-148
Published Date: 27 June 2016
Optimal management of genital herpes: current perspectives
Sauerbrei A
Infection and Drug Resistance 2016, 9:129-141
Published Date: 13 June 2016
Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
Jones TM, Johnson SW, DiMondi VP, Wilson DT
Infection and Drug Resistance 2016, 9:119-128
Published Date: 7 June 2016
Conceptual framework for outcomes research studies of hepatitis C: an analytical review
Sbarigia U, Denee TR, Turner NG, Wan GJ, Morrison A, Kaufman AS, Rice G, Dusheiko GM
Infection and Drug Resistance 2016, 9:101-117
Published Date: 27 May 2016
Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay: the clinical significance of toxin negativity in glutamate dehydrogenase-positive patients
Yuhashi K, Yagihara Y, Misawa Y, Sato T, Saito R, Okugawa S, Moriya K
Infection and Drug Resistance 2016, 9:93-99
Published Date: 27 May 2016
Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range
Phillips CJ, Wells NA, Martinello M, Smith S, Woodman RJ, Gordon DL
Infection and Drug Resistance 2016, 9:87-92
Published Date: 31 May 2016
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
Donnelley MA, Zhu ES, Thompson GR 3rd
Infection and Drug Resistance 2016, 9:79-86
Published Date: 2 June 2016
Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma
Watters CM, Burton T, Kirui DK, Millenbaugh NJ
Infection and Drug Resistance 2016, 9:71-78
Published Date: 27 April 2016
Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
Hawkshead III JJ, Van Dyke RB, Hassig SE, Webber LS, Begue RE
Infection and Drug Resistance 2016, 9:59-70
Published Date: 18 April 2016
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
Gonzalez-Ruiz A, Seaton RA, Hamed K
Infection and Drug Resistance 2016, 9:47-58
Published Date: 15 April 2016
Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
Rustomjee R, Zumla A
Infection and Drug Resistance 2016, 9:43-45
Published Date: 1 April 2016
Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature
Chipolombwe J, Török ME, Mbelle N, Nyasulu P
Infection and Drug Resistance 2016, 9:35-42
Published Date: 12 February 2016
Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus
Potashman MH, Stokes M, Liu J, Lawrence R, Harris L
Infection and Drug Resistance 2016, 9:19-33
Published Date: 28 January 2016
Pseudomonas aeruginosa ventilator-associated pneumonia management
Ramírez-Estrada S, Borgatta B, Rello J
Infection and Drug Resistance 2016, 9:7-18
Published Date: 20 January 2016
A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections
Gupta AK, Daigle D
Infection and Drug Resistance 2016, 9:1-6
Published Date: 18 January 2016